ArrowMark Colorado Holdings’s Gilead Sciences GILD Stock Holding History

ArrowMark Colorado Holdings’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-11,734	Closed	-$797K	–	320
2017 Q1	$797K	Sell	11,734 -836	-7%	-$58.8K	0.01%	261
2016 Q4	$900K	Hold	12,570	–	–	0.01%	246
2016 Q3	$995K	Hold	12,570	–	–	0.02%	233
2016 Q2	$1.05M	Hold	12,570	–	–	0.02%	221
2016 Q1	$1.16M	Sell	12,570 -2,930	-19%	-$264K	0.03%	210
2015 Q4	$1.57M	Hold	15,500	–	–	0.04%	209
2015 Q3	$1.52M	Buy	15,500 +4,910	+46%	+$545K	0.04%	207
2015 Q2	$1.24M	Buy	+10,590	New	+$1.16M	0.03%	227
2014 Q3	–	Sell	-35,078	Closed	-$2.91M	–	303
2014 Q2	$2.91M	Sell	35,078 -21,150	-38%	-$1.65M	0.08%	174
2014 Q1	$3.98M	Sell	56,228 -3,572	-6%	-$280K	0.13%	149
2013 Q4	$4.49M	Buy	59,800 +7,917	+15%	+$551K	0.14%	155
2013 Q3	$3.26M	Buy	51,883 +3,633	+8%	+$217K	0.11%	163
2013 Q2	$2.47M	Buy	+48,250	New	+$2.51M	0.67%	43

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ArrowMark Colorado Holdings's GILD Position: Q2 2017 in Review

ArrowMark Colorado Holdings sold out of Gilead Sciences (GILD) in Q2 2017, closing a stake of 11,734 shares — an estimated $797K sold.

ArrowMark Colorado Holdings first reported a position in GILD in Q2 2013 and held it in 13 quarters. The position peaked at $4.49M in Q4 2013. 1,519 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

ArrowMark Colorado Holdings reported no remaining Gilead Sciences position as of Q2 2017 after selling out during the quarter.
ArrowMark Colorado Holdings sold 11,734 Gilead Sciences shares in Q2 2017, an estimated $797K.
ArrowMark Colorado Holdings first reported a position in Gilead Sciences in Q2 2013 and held it in 13 quarters.
ArrowMark Colorado Holdings's Gilead Sciences position peaked at $4.49M in Q4 2013.
1,519 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on ArrowMark Colorado Holdings's 13F filing for Q2 2017, filed 14 Aug 2017.